Access to anti-retroviral drugs, female in Luxembourg
Luxembourg: Access to anti-retroviral drugs, female was 87.0% in 2024. ▲ Rising
Access to anti-retroviral drugs, female in Luxembourg, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
Luxembourg recorded 87.0% for access to anti-retroviral drugs, female in 2024. That is the highest value across all 25 years on record.
The figure is up 1.2% on the previous year and up 35.9% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Luxembourg peaked at 87.0% in 2024 and was at its lowest, 35.0%, in 2000.
Luxembourg ranks 45th of 141 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 25 years of available data.
Access to anti-retroviral drugs, female in Luxembourg, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 35.0% | — |
| 2001 | 35.0% | +0.0% |
| 2002 | 39.0% | +11.4% |
| 2003 | 38.0% | -2.6% |
| 2004 | 41.0% | +7.9% |
| 2005 | 49.0% | +19.5% |
| 2006 | 50.0% | +2.0% |
| 2007 | 47.0% | -6.0% |
| 2008 | 48.0% | +2.1% |
| 2009 | 51.0% | +6.2% |
| 2010 | 53.0% | +3.9% |
| 2011 | 55.0% | +3.8% |
| 2012 | 60.0% | +9.1% |
| 2013 | 59.0% | -1.7% |
| 2014 | 64.0% | +8.5% |
| 2015 | 68.0% | +6.2% |
| 2016 | 69.0% | +1.5% |
| 2017 | 70.0% | +1.4% |
| 2018 | 71.0% | +1.4% |
| 2019 | 72.0% | +1.4% |
| 2020 | 72.0% | +0.0% |
| 2021 | 73.0% | +1.4% |
| 2022 | 83.0% | +13.7% |
| 2023 | 86.0% | +3.6% |
| 2024 | 87.0% | +1.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 43.3% | 35.0% | 51.0% | 10 |
| 2010s | 64.1% | 53.0% | 72.0% | 10 |
| 2020s | 80.2% | 72.0% | 87.0% | 5 |
Countries ranked near Luxembourg
More gender data for Luxembourg
- Child population (UN estimates and projections) 109.93 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 0.2279 % change on previous year (2030)
- Population 603.74 (2030)
- Working-age population (UN estimates and projections) 603.74 (2030)
- Population (UN estimates and projections), annual growth rate 0.9746 % change on previous year (2030)
- Age population, age 00, female, interpolated 3,442 (2025)
- Age population, age 00, male, interpolated 3,621 (2025)
- Age population, age 01, female, interpolated 3,483 (2025)
- Age population, age 01, male, interpolated 3,657 (2025)
- Age population, age 02, female, interpolated 3,400 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Luxembourg?
- Access to anti-retroviral drugs, female in Luxembourg was 87.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Luxembourg?
- The highest recorded value was 87.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Luxembourg?
- The lowest recorded value was 35.0% in 2000.
- How does Luxembourg rank for access to anti-retroviral drugs, female?
- Luxembourg ranks 45th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Luxembourg?
- Over the last ten years it is up 35.9%. The long-run trend across the full record is rising.
- Where does this Luxembourg data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.